You are here:

Abbott Laboratories

Name SMC ID No Status Sub. Type
 
adalimumab (Humira) 533/09 Superseded Abbreviated Submission
adalimumab (Humira) 738/11 Superseded Abbreviated Submission
adalimumab (Humira) 800/12 Superseded Non submission
adalimumab (Humira) 824/12 Not Recommended Non submission
adalimumab (Humira) 81/03 Superseded Full submission
adalimumab (Humira) 218/05 Superseded Full submission
adalimumab (Humira) 468/08 Restricted Full submission
adalimumab 40mg pre-filled syringe (Humira) 300/06 Superseded Full submission
adalimumab 40mg solution for injection (Humira) 417/07 Superseded Full submission
lopinavir 200 mg, ritonavir 50 mg tablet (Kaletra) 326/06 Accepted Abbreviated Submission
paricalcitol 5 micrograms/ml and 10 micrograms/ml solution for injection (Zemplar) 288/06 Not Recommended Resubmission
paricalcitol 5mcg/ml and 10mcg/2ml solution for Injection (Zemplar) 288/06 Not Recommended Full submission
paricalcitol capsules 1,2 and 4 micrograms (Zemplar) 478/08 Not Recommended Full submission
racecadotril (Hidrasec Infants, Hidrasec Children) 818/12 Not Recommended Full submission
racecadotril (Hidrasec) 832/12 Not Recommended Non submission

Back